The improving-intestinal-microbial-balance properties of lactic acid bacteria (LAB) are well known. Thus, LAB could play a vital role in the pathogenesis of liver diseases. In the present study, 107 LAB strains were isolated from Mongolian camel milk products and identified to species, then screened for their probiotic properties. As a result, we identified 71 Lactobacillus bacteria belonging to 9 different species, and 36 Lactococcus bacteria belonging to 8 different species. Among them, six strains of LAB with strong tolerance and adhesion ability were further studied for their protective effect on acute liver injury induced by lipopolysaccharide (LPS)/D-galactosamine (D-GalN). These six strains of LAB were fed to mice for 7 weeks, and on the final day of the experiment, LPS/D-GalN were used to induce acute liver injury. After challenging, the degree of liver pathological changes, secretion of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum and liver, and the expression of tumour necrosis factor (TNF)-α and interleukin (IL)-6 in the liver and intestines were observed and quantified. The results showed that the degree of liver pathological changes in mice fed with the six LAB strains were relieved to varying degrees compared with the LPS/D-GalN-induced model group, and the expressions of AST, ALT, IL-6, and TNF-α factor were also significantly decreased. Moreover, the expression levels of these factors in mice pretreated with Lactobacillus paracasei subsp. paracasei WXD5 were significantly decreased compared with other experimental groups. This suggests the probiotic potential and pharmacological value of L. paracasei subsp. paracasei as a liver injury inhibitor in the intervention of inflammation-based liver disease.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Abushelaibi, A., Al-Mahadin, S., El-Tarabily, K., Shah, N.P. and Ayyash, M., 2017. Characterization of potential probiotic lactic acid bacteria isolated from camel milk. LWT â Food Science and Technology 79: 316-325. DOI: https://doi.org/10.1016/j.lwt.2017.01.041
Ayyash, M., Abushelaibi, A., Al-Mahadin, S., Enan, M., El-Tarabily, K. and Shah, N., 2018. In-vitro investigation into probiotic characterisation of Streptococcus and Enterococcus isolated from camel milk. LWT â Food Science and Technology 87: 478-487. DOI: https://doi.org/10.1016/j.lwt.2017.09.019
Cesaro, C., Tiso, A., Del Prete, A., Cariello, R., Tuccillo, C., Cotticelli, G., Blanco, C.V., Duan, C., Zhao, Y., Huang, C., Zhao, Z., Gao, L., Niu, C., Wang, C., Liu, X., Zhang, C. and Li, S., 2018. Hepatoprotective effects of Lactobacillus plantarum C88 on LPS/D-GalN-induced acute liver injury in mice. Journal of Functional Foods 43: 146-153.
'Hepatoprotective effects of Lactobacillus plantarum C88 on LPS/D-GalN-induced acute liver injury in mice ' () 43 Journal of Functional Foods : 146 -153.
Duan, G.J., Zhu, J., Xu, C.Y., Wan, J.Y., Zhang, L., Ge, X.D., Liu, L.M. and Liu, Y.S., 2011. Protective effect of GÃ6976, a PKD inhibitor, on LPS/D-GalN-induced acute liver injury in mice. Inflammation Research 60: 357-366.
'Protective effect of GÃ6976, a PKD inhibitor, on LPS/D-GalN-induced acute liver injury in mice ' () 60 Inflammation Research : 357 -366.
Khan, A.A., Alzohairy, M.A. and Mohieldein, A.H., 2012. Antidiabetic effects of camel milk in streptozotocin-induced diabetic rats. American Journal of Biochemistry and Molecular Biology 3: 151-158.
'Antidiabetic effects of camel milk in streptozotocin-induced diabetic rats ' () 3 American Journal of Biochemistry and Molecular Biology : 151 -158.
Kumar, S., Tamura, K. and Nei, M., 2004. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Briefings in Bioinformatics 5: 150-163.
'MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment ' () 5 Briefings in Bioinformatics : 150 -163.
Küsters, S.S., 2010. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. European Journal of Immunology 27(11): 2870-2875.
'In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis ' () 27 European Journal of Immunology : 2870 -2875.
Lechner, A.J., Velasquez, A., Knudsen, K.R., Johanns, C.A., Tracy Jr., T.F., Matuschak, G.M., 1998. Cholestatic liver injury increase circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. American Journal of Respiratory and Critical Care Medicine 157: 1550-1558.
'Cholestatic liver injury increase circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia ' () 157 American Journal of Respiratory and Critical Care Medicine : 1550 -1558.
Li, L., Duan, C., Zhao, Y., Zhang, X., Yin, H., Wang, T., Huang, C., Liu, S., Yang, S. and Li, X., 2017. Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages. International Immunopharmacology 51: 99-106.
'Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages ' () 51 International Immunopharmacology : 99 -106.
Liu, A., Shen, Y., Du, Y., Chen, J., Pei, F., Fu, W. and Qiao, J., 2018. Esculin prevents lipopolysaccharide/D-galactosamine-induced acute liver injury in mice. Microbial Pathogenesis 125: 418-422.
'Esculin prevents lipopolysaccharide/D-galactosamine-induced acute liver injury in mice ' () 125 Microbial Pathogenesis : 418 -422.
Marshall, J.C., 2005. Lipopolysaccharide: an endotoxin or an exogenous hormone? Clinical Infectious Diseases 41, Suppl. 7: S470-S80.
'Lipopolysaccharide: an endotoxin or an exogenous hormone? ' () 7 : S470 -S80.
Nepali, S., Ki, H.H., Lee, J.H., Lee, H.Y., Kim, D.K. and Lee, Y.M., 2017. Wheatgrass-derived polysaccharide has anti-inflammatory, anti-oxidative and anti-apoptotic effects on LPS-induced hepatic injury in mice. Phytotherapy Research 31: 1107-1116.
'Wheatgrass-derived polysaccharide has anti-inflammatory, anti-oxidative and anti-apoptotic effects on LPS-induced hepatic injury in mice ' () 31 Phytotherapy Research : 1107 -1116.
Nolan, J.P., 2010. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 52: 1829-1835.
'The role of intestinal endotoxin in liver injury: a long and evolving history ' () 52 Hepatology : 1829 -1835.
Rishi, P., Bharrhan, S., Singh, G. and Kaur, I.P., 2011. Effect of Lactobacillus plantarum and l-arginine against endotoxin-induced liver injury in a rat model. Life Sciences 89: 847-853.
'Effect of Lactobacillus plantarum and l-arginine against endotoxin-induced liver injury in a rat model ' () 89 Life Sciences : 847 -853.
Shori, A.B., 2015. Camel milk as a potential therapy for controlling diabetes and its complications: a review of in vivo studies. Journal of Food and Drug Analysis 23: 609-618.
'Camel milk as a potential therapy for controlling diabetes and its complications: a review of in vivo studies ' () 23 Journal of Food and Drug Analysis : 609 -618.
Shori, A.B., 2017. Camel milk and its fermented products as a source of potential probiotic strains and novel food cultures: a mini review. Pharma Nutrition 5: 84-88.
'Camel milk and its fermented products as a source of potential probiotic strains and novel food cultures: a mini review ' () 5 Pharma Nutrition : 84 -88.
Szabo, G. and Petrasek, J., 2017. Gut-liver axis and sterile signals in the development of alcoholic liver disease. Alcohol and Alcoholism 52: 414.
'Gut-liver axis and sterile signals in the development of alcoholic liver disease ' () 52 Alcohol and Alcoholism : 414.
Wang, Y., Li, Y., Xie, J., Zhang, Y., Wang, J., Sun, X. and Zhang, H., 2013. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. International Immunopharmacology 15: 30-37.
'Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities ' () 15 International Immunopharmacology : 30 -37.
Wang, Z., Zhang, W., Wang, B., Zhang, F. and Shao, Y., 2018. Influence of Bactrian camel milk on the gut microbiota. Journal of Dairy Science 101: 5758-5769.
'Influence of Bactrian camel milk on the gut microbiota ' () 101 Journal of Dairy Science : 5758 -5769.
Xia, X., Su, C., Fu, J., Zhang, P., Jiang, X., Xu, D., Hu, L., Song, E. and Song, Y., 2014. Role of α-lipoic acid in LPS/D-GalN induced fulminant hepatic failure in mice: Studies on oxidative stress, inflammation and apoptosis. International Immunopharmacology 22: 293-302.
'Role of α-lipoic acid in LPS/D-GalN induced fulminant hepatic failure in mice: Studies on oxidative stress, inflammation and apoptosis ' () 22 International Immunopharmacology : 293 -302.
Yang, F., Li, X., Wang, L.K., Wang, L.W., Han, X.Q., Zhang, H. and Gong, Z.J., 2014. Inhibitions of NF-kappaB and TNF-alpha result in differential effects in rats with acute on chronic liver failure induced by D-Gal and LPS. Inflammation 37: 848-857.
'Inhibitions of NF-kappaB and TNF-alpha result in differential effects in rats with acute on chronic liver failure induced by D-Gal and LPS ' () 37 Inflammation : 848 -857.
Yang, S., Yu, M., Sun, L., Xiao, W., Yang, X., Sun, L., Zhang, C., Ma, Y., Yang, H., Liu, Y., Lu, D., Teitelbaum, D.H. and Yang, H., 2014. Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. Journal of Interferon and Cytokine Research 34: 195-203.
'Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway ' () 34 Journal of Interferon and Cytokine Research : 195 -203.
Zhao, L., Jiang, Y., Ni, Y.X., Zhang, T.Z., Duan, C.C., Huang, C., Zhao, Y.J., Gao, L. and Li, S.Y., 2017. Protective effects of Lactobacillus plantarum C88 on chronic ethanol-induced liver injury in mice. Journal of Functional Foods 35: 97-104.
'Protective effects of Lactobacillus plantarum C88 on chronic ethanol-induced liver injury in mice ' () 35 Journal of Functional Foods : 97 -104.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 402 | 118 | 16 |
| å ¨ææµè§æ¬¡æ° | 5 | 1 | 0 |
| PDFä¸è½½æ¬¡æ° | 6 | 0 | 0 |
The improving-intestinal-microbial-balance properties of lactic acid bacteria (LAB) are well known. Thus, LAB could play a vital role in the pathogenesis of liver diseases. In the present study, 107 LAB strains were isolated from Mongolian camel milk products and identified to species, then screened for their probiotic properties. As a result, we identified 71 Lactobacillus bacteria belonging to 9 different species, and 36 Lactococcus bacteria belonging to 8 different species. Among them, six strains of LAB with strong tolerance and adhesion ability were further studied for their protective effect on acute liver injury induced by lipopolysaccharide (LPS)/D-galactosamine (D-GalN). These six strains of LAB were fed to mice for 7 weeks, and on the final day of the experiment, LPS/D-GalN were used to induce acute liver injury. After challenging, the degree of liver pathological changes, secretion of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum and liver, and the expression of tumour necrosis factor (TNF)-α and interleukin (IL)-6 in the liver and intestines were observed and quantified. The results showed that the degree of liver pathological changes in mice fed with the six LAB strains were relieved to varying degrees compared with the LPS/D-GalN-induced model group, and the expressions of AST, ALT, IL-6, and TNF-α factor were also significantly decreased. Moreover, the expression levels of these factors in mice pretreated with Lactobacillus paracasei subsp. paracasei WXD5 were significantly decreased compared with other experimental groups. This suggests the probiotic potential and pharmacological value of L. paracasei subsp. paracasei as a liver injury inhibitor in the intervention of inflammation-based liver disease.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 402 | 118 | 16 |
| å ¨ææµè§æ¬¡æ° | 5 | 1 | 0 |
| PDFä¸è½½æ¬¡æ° | 6 | 0 | 0 |